Evidence map›Paper›PMID 37259469›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Developing In Situ Chemometric Models with Raman Spectroscopy for Monitoring an API Disproportionation with a Complex Polymorphic Landscape.

Shikhar Mohan, Yi Li, Kevin Chu, Bing Shi, Liliana De La Paz, Prarthana Bakre, Chris Foti, Victor Rucker, Chiajen Lai

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shikhar MohanGilead Sciences, Foster City, CA 94404, USA.
Yi LiGilead Sciences, Foster City, CA 94404, USA.
Kevin ChuVelexi Corporation, Burlingame, CA 94010, USA.
Bing ShiGilead Sciences, Foster City, CA 94404, USA.
Liliana De La PazGilead Sciences, Foster City, CA 94404, USA.
Prarthana BakreInformation Systems, Naveen Jindal School of Management, The University of Texas at Dallas, Richardson, TX 75080, USA.
Chris FotiGilead Sciences, Foster City, CA 94404, USA.
Victor RuckerGilead Sciences, Foster City, CA 94404, USA.
Chiajen LaiGilead Sciences, Foster City, CA 94404, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An in situ Raman method was developed to characterize the disproportionation of two salts involving a complex polymorphic landscape comprising up to two metastable and one stable freebase forms. Few precedents exist for Raman calibration procedures for solid form quantitation involving more than two polymorphs, while no literature examples were found for cases with multiple metastable forms. Therefore, a new Raman calibration procedure was proposed by directly using disproportionation experiments to generate multiple calibration samples encompassing a range of polymorph ratios through in-line Raman measurements complemented by off-line reference X-ray diffraction measurements. The developed Raman methods were capable of accurately quantitating each solid form in situ when solid concentration variation was incorporated into the calibration dataset. The kinetic understanding of the thermodynamically driven polymorphic conversions gained from this Raman method guided the selection of the salt best suited for the delivery of the active ingredient in the drug product. This work provided a spectroscopic and mathematical approach for simultaneously quantitating multiple polymorphs from a complex mixture of solids with the objective of real-time monitoring.

Indexed as

process analytical technologyprocess monitoringRaman spectroscopysalt disproportionationX-ray diffraction

Identifiers

PMID37259469
PMCPMC9964727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.